Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

Figure 4

Expression of JMJD6 enhances proliferation. (A) WST-1 assays using MCF-7-J1-OE clones (J1-C2, J1-C3, and J1-C7) showed increased proliferation over vector control cells (Vec). SiRNA-mediated knockdown of JMJD6 and resultant decrease in proliferation is shown in (B) MCF-7 and MDA-MB231. Four individual siRNAs (A, B, C, and D) were used: Sc, scrambled siRNA; and NT, non-transfected cells served as control. Inset in each panel shows protein levels of JMJD6 after siRNA transfection. β-actin immunoblots show equal protein loading in all lanes.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us